The pooled analysis of 2 unpublished trials of DJ, a traditional Chinese medicine currently approved in China to improve neurological recovery after stroke, shows good tolerability and superiority of DJ over another traditional Chinese medicine also approved for stroke. A large double-blind randomized clinical trial is required to further assess the safety and efficacy of DJ.
Authors: Christopher Chen, Narayanaswamy Venketasubramanian, Robert Gan, Caroline Lambert, D. Picard, Bernard P.L. Chan, Edwin Chan, Marie Germaine Bousser, Xuemin Shi
DOI: https://doi.org/10.1161/strokeaha.108.531616
Publish Year: 2009
